Liang et al. have shown that DLX1 is upregulated in the prostate clinical samples and exerts its oncogenic roles on PCa by activating β-catenin/TCF signaling and promoting the growth and migration of PCa cells [63]. This evidence concerns the gene DLX1 and posterior cortical atrophy.